DEA's Los Angeles Field Division recently announced Operation Faux Pharmacy, a multi-pronged initiative aimed at attacking the opioid epidemic by targeting rogue pharmacies throughout southern California, Hawaii, and Nevada. DEA investigations over the last year identified as many as 26 pharmacies in these areas that may have operated outside the bounds of legitimate medicine. "DEA is fighting the opioid crisis on multiple levels, using every resource available to identify reckless doctors and rogue businesses that fuel addiction in our neighborhoods and communities," said DEA Acting Administrator Robert W. Patterson. As part of this initiative, DEA special agents, diversion investigators, and intelligence analysts examined data that manufacturers and distributors report to DEA, Prescription Drug Monitoring Program information, and HHS data to determine those most likely to be operating as drug traffickers disguised as legitimate pharmacies. Common indicators include pharmacies that had filled exceptionally high numbers of oxycodone prescriptions, excessive or frequent opioid purchases, multiple customers with identical addresses, or customers traveling extreme distances to specific pharmacies despite access to more convenient options. To date, Operation Faux Pharmacy has seized close to 600,000 dosage units of scheduled drugs. The investigation is ongoing and violators of the Controlled Substances Act may face administrative, civil, and criminal penalties.